Robert Karsunky
Robert Karsunky is an angel investor based in Switzerland, investing in Energy, Environment & Mobility; Aviation and Mobility Tech, 1 tracked investment.
About Robert Karsunky
Robert Karsunky is an angel investor headquartered in Switzerland. We have recorded 1 investment for Robert Karsunky to date.
Sector activity concentrates in Energy, Environment & Mobility; Aviation; Mobility Tech and Sustainability. Coverage extends to 8 sectors in total. Investments are concentrated at Series A.
Cellestia Biotech is a clinical-stage biopharma company focused on developing precision oncology therapies through selective inhibition of transcription factors. Their lead candidate, CB-103, is a first-in-class oral pan-NOTCH inhibitor for treating NOTCH-dependent cancers.
Investment Focus
Investment Thesis
Cellestia Biotech is a clinical-stage biopharma company focused on developing precision oncology therapies through selective inhibition of transcription factors. Their lead candidate, CB-103, is a first-in-class oral pan-NOTCH inhibitor for treating NOTCH-dependent cancers.
Explore Robert Karsunky's full profile on Brouky
Portfolio companies, co-investors, AI match scores, and deal flow signals.
Other Investors in Switzerland
Road Ventures
Commerce & Marketing, Finance & Blockchain, Industry & Hardware
RKKVC
Industry & Hardware, Software & Developer Tools, Artificial Intelligence & Data
Ringier Digital Ventures
Consumer, Lifestyle & Services, Commerce & Marketing, Software & Developer Tools
Richemont
Commerce & Marketing, ecommerce, fashion
Roche
Healthcare & Life Sciences, Industry & Hardware, Software & Developer Tools
Roche Ventures
Healthcare & Life Sciences, Health Data & IT, biotechnology
Roger Federer
Software & Developer Tools, artificial intelligence, FoodTech
Roger Studer
Finance & Blockchain, crypto, custody